Fri Sep 05 11:29:30 UTC 2025: **Summary:**

Yasmeen Wankhede, sister of former NCB zonal director Sameer Wankhede, has filed a protest petition against a police report that cleared NCP leader Nawab Malik of defamation charges. Wankhede alleges Malik made false and defamatory statements against her following her brother’s involvement in drug-related cases, including one involving Malik’s son-in-law. She claims the police investigation was biased due to Malik’s influence and that he misused her personal photographs for his own agenda. The next hearing is scheduled for September 22.

**News Article:**

**Wankhede Sister Alleges Bias in Defamation Case Against NCP Leader Malik**

**Mumbai – September 5, 2025** – Yasmeen Wankhede, sister of former Narcotics Control Bureau (NCB) zonal director Sameer Wankhede, is challenging a police report that cleared Nationalist Congress Party (NCP) leader Nawab Malik of defamation charges. Wankhede filed a protest petition on Wednesday, alleging that the police investigation into her 2021 complaint was biased and influenced by Malik, a former Maharashtra Minister.

In her initial complaint, Wankhede accused Malik of making false and defamatory statements against her in tweets and television interviews following her brother’s involvement in high-profile drug cases, including one against Malik’s son-in-law. The Bandra magistrate court ordered an inquiry, but the subsequent police report gave Malik a clean chit, stating there was no evidence of a cognizable offence.

Wankhede’s petition claims the police report attempts to justify Malik’s actions, which she argues are contrary to the law. Her lawyer asserts that Malik misused private photographs from her Instagram account for his own agenda, even if he claims his statements were made in his capacity as a party spokesperson.

“Police authorities have failed to investigate the matter without any unbiasedness,” the petition states.

The complaint also suggests that Malik’s actions were motivated by vengeance due to Sameer Wankhede’s involvement in drug-related cases. The next hearing on the matter is scheduled for September 22.

Read More